219 related articles for article (PubMed ID: 33156834)
1. Transcriptional analysis of immune response genes during pathogenesis of cytomegalovirus retinitis in mice with murine acquired immunodeficiency syndrome.
Carter JJ; Gardner JM; Poling BP; Welch MM; Nemeno JGE; Houghton JE; Dix RD
PLoS Pathog; 2020 Nov; 16(11):e1009032. PubMed ID: 33156834
[TBL] [Abstract][Full Text] [Related]
2. Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 Are Stimulated within the Eye during Experimental Murine Cytomegalovirus Retinitis in Mice with Retrovirus-Induced Immunosuppression.
Chien H; Alston CI; Dix RD
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976680
[TBL] [Abstract][Full Text] [Related]
3. Atypical cytomegalovirus retinal disease in pyroptosis-deficient mice with murine acquired immunodeficiency syndrome.
Carter JJ; Nemeno JGE; Oh JJ; Houghton JE; Dix RD
Exp Eye Res; 2021 Aug; 209():108651. PubMed ID: 34097907
[TBL] [Abstract][Full Text] [Related]
4. Evidence for multiple cell death pathways during development of experimental cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression: apoptosis, necroptosis, and pyroptosis.
Chien H; Dix RD
J Virol; 2012 Oct; 86(20):10961-78. PubMed ID: 22837196
[TBL] [Abstract][Full Text] [Related]
5. Murine cytomegalovirus downregulates interleukin-17 in mice with retrovirus-induced immunosuppression that are susceptible to experimental cytomegalovirus retinitis.
Blalock EL; Chien H; Dix RD
Cytokine; 2013 Mar; 61(3):862-75. PubMed ID: 23415673
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the involvement of interleukin-1α during development of experimental cytomegalovirus retinitis in immunosuppressed mice.
Mora Scarpetta GA; Carter JJ; Nemeño JGE; Dix RD
Cytokine; 2021 Aug; 144():155596. PubMed ID: 34078571
[TBL] [Abstract][Full Text] [Related]
7. Loss of the perforin cytotoxic pathway predisposes mice to experimental cytomegalovirus retinitis.
Dix RD; Podack ER; Cousins SW
J Virol; 2003 Mar; 77(6):3402-8. PubMed ID: 12610115
[TBL] [Abstract][Full Text] [Related]
8. Parthanatos-associated proteins are stimulated intraocularly during development of experimental murine cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression.
Oh JJ; Carter JJ; Nemeno JGE; Dix RD
J Med Virol; 2020 Mar; 92(3):394-398. PubMed ID: 31670405
[TBL] [Abstract][Full Text] [Related]
9. Reduced frequency of murine cytomegalovirus retinitis in C57BL/6 mice correlates with low levels of suppressor of cytokine signaling (SOCS)1 and SOCS3 expression within the eye during corticosteroid-induced immunosuppression.
Alston CI; Dix RD
Cytokine; 2017 Sep; 97():38-41. PubMed ID: 28558309
[TBL] [Abstract][Full Text] [Related]
10. Antibody alone does not prevent experimental cytomegalovirus retinitis in mice with retrovirus-induced immunodeficiency (MAIDS).
Dix RD; Cray C; Cousins SW
Ophthalmic Res; 1997; 29(6):381-92. PubMed ID: 9380340
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to murine cytomegalovirus retinitis during progression of MAIDS: correlation with intraocular levels of tumor necrosis factor-alpha and interferon-gamma.
Dix RD; Cousins SW
Curr Eye Res; 2004; 29(2-3):173-80. PubMed ID: 15512964
[TBL] [Abstract][Full Text] [Related]
12. Mice immunosuppressed by murine retrovirus infection (MAIDS) are susceptible to cytomegalovirus retinitis.
Dix RD; Cray C; Cousins SW
Curr Eye Res; 1994 Aug; 13(8):587-95. PubMed ID: 7956311
[TBL] [Abstract][Full Text] [Related]
13. Murine cytomegalovirus retinitis during retrovirus-induced immunodeficiency (MAIDS) in mice: interleukin-2 immunotherapy correlates with increased intraocular levels of perforin mRNA.
Dix RD; Podack ER; Cousins SW
Antiviral Res; 2003 Jul; 59(2):111-9. PubMed ID: 12895694
[TBL] [Abstract][Full Text] [Related]
14. Systemic cytokine immunotherapy for experimental cytomegalovirus retinitis in mice with retrovirus-induced immunodeficiency.
Dix RD; Giedlin M; Cousins SW
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1411-7. PubMed ID: 9191604
[TBL] [Abstract][Full Text] [Related]
15. Murine cytomegalovirus retinitis during MAIDS: Susceptibility correlates with elevated intraocular levels of interleukin-4 mRNA.
Dix R; Cousins S
Curr Eye Res; 2003; 26(3-4):211-7. PubMed ID: 12815549
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 immunotherapy of murine cytomegalovirus retinitis during MAIDS correlates with increased intraocular CD8+ T-cell infiltration.
Dix RD; Cousins SW
Ophthalmic Res; 2003; 35(3):154-9. PubMed ID: 12711843
[TBL] [Abstract][Full Text] [Related]
17. A Mouse Model That Mimics AIDS-Related Cytomegalovirus Retinitis: Insights into Pathogenesis.
Oh JJ; Carter JJ; Dix RD
Pathogens; 2021 Jul; 10(7):. PubMed ID: 34358000
[TBL] [Abstract][Full Text] [Related]
18. Systemic murine cytomegalovirus infection of mice with retrovirus-induced immunodeficiency results in ocular infection but not retinitis.
Dix RD
Ophthalmic Res; 1998; 30(5):295-301. PubMed ID: 9704333
[TBL] [Abstract][Full Text] [Related]
19. Perforin knockout mice, but not mice with MAIDS, show protection against experimental cytomegalovirus retinitis after adoptive transfer of immune cells with a functional perforin cytotoxic pathway.
Dix RD; Ekworomadu CO; Hernandez E; Cousins SW
Arch Virol; 2004 Nov; 149(11):2235-44. PubMed ID: 15503209
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-2 immunotherapy and AIDS-related cytomegalovirus retinitis.
Dix RD; Cousins SW
Curr HIV Res; 2004 Oct; 2(4):333-42. PubMed ID: 15544454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
